- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jeffrey Gudin: PDMPs Are Getting Better, but Still Room for Improvement
There are 2 ways prescription drug monitoring programs can improve, said Jeffrey Gudin, MD, Pain Management and Palliative Care at Englewood Hospital and Medical Center.
There are 2 ways prescription drug monitoring programs can improve, said Jeffrey Gudin, MD, Pain Management and Palliative Care at Englewood Hospital and Medical Center.
Transcript
How can prescription drug monitoring programs be improved?
So the prescription drug monitoring programs have been getting better every year. We started out with a relatively archaic system which only screened one state and that has morphed into a fully electronic database that you can screen multiple states. I’d say there’s 2 ways that we can make our prescription drug monitoring programs better. One, have it become national, and I know there’s some push to get that done so we can screen patients who snowbird in Arizona or North Carolina or Florida, when they’re living in New York or New Jersey. And the other way is to include all medications in the prescription drug monitoring program. Now that sounds like a big task, but there are some of the electronic record systems that already do it and are able to scan the national pharmacy databases and give you an idea of the medications that your patients take, because we have drug-drug interactions that happen not just with controlled substances but also with everyday medicines as well. I think those are ways we can improve the program.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
